Good symptom management in oncology is associated with improved patient and family
quality of life, greater treatment compliance, and may even offer survival advantages. With …

Aim To assess the relative effects of different types of exercise and other non-
pharmaceutical interventions on cancer-related fatigue (CRF) in patients during and after …

Immune checkpoint inhibitors (ICIs) are the standard of care for the treatment of several
cancers. While these immunotherapies have improved patient outcomes in many clinical …

Purpose Treatment with programmed cell death-1 or programmed death ligand 1 (PD-(L) 1)
inhibitors is now standard therapy for patients with lung cancer. The immunosuppressive …

Cancer-related fatigue is defined as a distressing, persistent, subjective sense of physical,
emotional, and/or cognitive tiredness or exhaustion related to cancer or cancer treatment …

Purpose This guideline presents screening, assessment, and treatment approaches for the
management of adult cancer survivors who are experiencing symptoms of fatigue after …

Purpose Cancer-related fatigue (CRF) is the most prevalent and distressing symptom
among cancer patients and survivors. However, research on its prevalence and related …

Background Cancer‐related fatigue is recognised as an important symptom associated with
cancer and its treatment. A number of studies have investigated the effects of physical …

Purpose Cancer-related fatigue (CRF) is the most common symptom in patients with
advanced cancer. The primary objective of this prospective, randomized, double-blind …

Cancer‐related fatigue (CRF) has been documented as 1 of the most distressing symptoms
reported by breast cancer survivors. CRF affects functioning and impacts quality of life …